X 
Financials Ratios
Home | Market Info | Company Profile | Financials Ratios
Brooks Laboratories Ltd.
BSE CODE: 533543   |   NSE CODE: BROOKS   |   ISIN CODE : INE650L01011   |   02-Apr-2026 16:00 Hrs IST
BSE NSE
Rs. 53.97
8.99 ( 19.99% )
 
Prev Close ( Rs.)
44.98
Open ( Rs.)
44.30
 
High ( Rs.)
53.97
Low ( Rs.)
44.30
 
Volume
93553
Week Avg.Volume
25984
 
52 WK High-Low Range(Rs.)
BSE NSE
Rs. 53.38
8.85 ( 19.87% )
 
Prev Close ( Rs.)
44.53
Open ( Rs.)
45.86
 
High ( Rs.)
53.43
Low ( Rs.)
45.21
 
Volume
935134
Week Avg.Volume
172569
 
52 WK High-Low Range(Rs.)
36.3
164.02
Particulars Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021
Operational & Financial Ratios          
   Earnings Per Share (Rs)1.04  0.58  -3.31  0.27  -6.31  
   CEPS(Rs)1.58  1.26  -2.59  0.86  -3.41  
   DPS(Rs)0.00  0.00  0.00  0.00  0.00  
   Book NAV/Share(Rs)39.06  26.49  22.98  26.31  25.99  
   Tax Rate(%)5.43  1.67  0.00  0.00  -84.79  
Margin Ratios          
   Core EBITDA Margin(%)1.66  3.86  -10.47  2.44  1.22  
   EBIT Margin(%)5.16  3.02  -13.35  1.74  -6.71  
   Pre Tax Margin(%)3.91  1.96  -14.73  0.87  -10.92  
   PAT Margin (%)3.70  1.92  -14.73  0.87  -20.17  
   Cash Profit Margin (%)5.64  4.15  -11.64  2.80  -10.99  
Performance Ratios          
   ROA(%)2.60  1.64  -8.36  0.68  -12.43  
   ROE(%)3.31  2.42  -13.44  1.03  -19.17  
   ROCE(%)4.35  3.50  -11.21  1.87  -5.24  
   Asset Turnover(x)0.70  0.85  0.57  0.78  0.62  
   Sales/Fixed Asset(x)3.41  3.45  2.53  3.78  1.02  
   Working Capital/Sales(x)7.48  9.93  -10.26  49.00  -224.44  
Efficiency Ratios          
   Fixed Capital/Sales(x)0.29  0.29  0.40  0.26  0.98  
   Receivable days80.26  66.75  91.32  58.39  59.40  
   Inventory Days41.59  48.02  91.65  68.68  61.77  
   Payable days98.11  125.11  221.56  144.92  150.71  
Valuation Parameters          
   PER(x)103.99  159.31  0.00  269.27  0.00  
   PCE(x)68.20  73.76  -23.92  83.33  -18.07  
   Price/Book(x)2.76  3.50  2.72  2.76  2.39  
   Yield(%)0.00  0.00  0.00  0.00  0.00  
   EV/Net Sales(x)3.90  3.12  2.87  2.38  2.08  
   EV/Core EBITDA(x)55.01  59.41  -27.94  64.91  84.53  
   EV/EBIT(x)75.70  103.31  -21.47  137.15  -31.04  
   EV/CE(x)2.66  3.32  2.55  1.77  1.73  
   M Cap / Sales3.84  3.06  2.78  2.33  1.99  
Growth Ratio          
   Net Sales Growth(%)3.86  43.12  -27.84  -0.40  10.89  
   Core EBITDA Growth(%)40.36  173.22  -301.95  48.12  154.19  
   EBIT Growth(%)77.34  132.36  -655.24  125.75  48.96  
   PAT Growth(%)99.62  118.68  -1328.69  104.27  36.05  
   EPS Growth(%)77.87  117.58  -1328.69  104.27  36.05  
Financial Stability Ratios          
   Total Debt/Equity(x)0.05  0.07  0.10  0.08  0.13  
   Current Ratio(x)1.48  1.35  0.84  1.04  0.99  
   Quick Ratio(x)1.08  0.93  0.49  0.58  0.50  
   Interest Cover(x)4.14  2.84  -9.67  1.99  -1.60  
   Total Debt/Mcap(x)0.02  0.02  0.04  0.03  0.05